Hyperphosphatemia: Its Consequences and Treatment in Patients With Chronic Renal Disease
References (122)
- et al.
Effect of parathyroid hormone on myocardial energy metabolism in the rat
Kidney Int
(1985) - et al.
Fatty acid oxidation in the myocardium: Effects of parathyroid hormone and CRF
Kidney Int
(1988) - et al.
Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle
Kidney Int
(1988) - et al.
Verapamil reverses PTH- or CRF-induced abnormal fatty acids oxidation in muscle
Kidney Int
(1988) - et al.
Effect of parathyroid hormone on energy metabolism of skeletal muscle
Kidney Int
(1985) - et al.
Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure
Kidney Int
(1989) - et al.
Insulin release from pancreatic islets:Effects of CRF and excess PTH
Kidney Int
(1988) - et al.
Myocardial calcification and cardiac dysfunction in chronic renal failure
Am J Med
(1988) - et al.
Disordered calcium and phosphorus metabolism during maintenance hemodialysis
Am J Med
(1971) - et al.
Soft tissue calcification in pediatric patients with end-stage renal disease
Kidney Int
(1990)
Stimulation of 25-hydroxyvitamin D31-alpha-hydroxylase by phosphate depletion
J Biol Chem
(1976)
The role of phosphate restriction in the prevention of secondary hyperparathyroidism in chronic renal disease
Kidney Int
(1973)
Determinations of serum 1,25(OH)2D levels in renal disease
Kidney Int
(1983)
Study of intestinal absorption of calcium in patients with renal failure
Kidney Int
(1973)
Effects of dietary protein and phosphorus restriction on the progression of early renal failure
Kidney Int
(1982)
The short-term effects of a low protein diet in stable renal transplant recipients
Am J Kidney Dis
(1991)
Effect of energy intake on nitrogen metabolism in nondialyzed patients in chronic renal failure
Kidney Int
(1986)
A mechanistic analysis of the National Cooperative Dialysis Study (NCDS)
Kidney Int
(1985)
Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis
Kidney Int
(1982)
Calcium and phosphorus fluxes during hemodialsis with low calcium dialysate
Am J Kidney Dis
(1991)
Effect of hematocrit on solute removal during high efficiency hemodialysis
Kidney Int
(1990)
Minerals, vitamin D and parathyroid hormone in continuous ambulatory peritoneal dialysis
Kidney Int
(1982)
Fracturing dialysis osteodystrophy and dialysis encephalopathy
An epidemiological survey. Lancet
(1979)
Clinical and laboratory features of aluminum-related bone disease
Differences between sporadic and epidemic forms of the syndrome. Am J Kidney Dis
(1985)
The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis
Kidney Int
(1973)
Oral calcium carbonate as a phosphate-binding agent in children on dialysis: Effect on plasma aluminum levels
J Pediatr
(1986)
Long term effects of calcium carbonate and 2.5 mEq/L calcium dialysate on mineral metabolism
Kidney Int
(1989)
Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy
Am J Kidney Dis
(1990)
Calcium acetate, an effective phosphorus binder in patients with renal failure
Kidney Int
(1989)
Calcium acetate control of serum phosphorus in hemodialysis patients
Am J Kidney Dis
(1991)
Calcium citrate, a nonaluminum-containing phosphate-binding agent for treatment of CRF
Kidney Int
(1988)
Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide
Am J Kidney Dis
(1991)
Influence of calcium acetate or calcium citrate on intestinal aluminum absorption
Kidney Int
(1990)
Site and mechanism of enhanced gastrointestinal absorption of aluminum by citrate
Kidney Int
(1989)
Effect of parathyroid hormone on rat heart cells
J Clin Invest
(1981)
Role of parathyroid hormone in the glucose intolerance of chronic renal failure
J Clin Invest
(1985)
Effect of parathyroid hormone on erythropoiesis
J Clin Invest
(1981)
Effect of parathyroid hormone on osmotic fragility of human erythrocytes
J Clin Invest
(1982)
Calcific cardiomyopathy in advanced renal failure
Arch Intern Med
(1975)
Calciphylaxis in man
Arch Intern Med
(1976)
Phosphate excess and progressive renal failure:The precipitation-calcification hypothesis
Kidney Int
(1989)
Chemical composition of the body
Absorption of calcium, phosphorus and magnesium
Oral intake of phosphorus can determine the serum concentrations of 1,25-dihydroxyvitamin D by determining its production rate in humans
J Clin Invest
(1986)
Dietary phosphate deprivation in women and men: Effects on mineral and acid balances, parathyroid hormone and the metabolism of 25-OH-vitamin D
J Clin Endocrinol Metab
(1976)
The role of phosphate in the secretion of parathyroid hormone in man
J Clin Invest
(1970)
Bone and soft tissue changes with oral phosphate supplements
J Clin Invest
(1972)
Long-term effects of high phosphate intake on parathyroid hormone levels and bone metabolism
Acta Orthop Scand
(1974)
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog
J Clin Invest
(1971)
The pathogenesis of secondary hyperparathyroidism in early renal failure
Cited by (228)
Colorimetric detection of phosphate-based on iron complexing catechol-displacement assay in eutrophicated water bodies
2023, Environmental Nanotechnology, Monitoring and ManagementBinding and inhibitory activities: A novel oral therapeutic agent for the treatment of hyperphosphataemia rats
2022, Biomedicine and PharmacotherapyCitation Excerpt :Chronic kidney disease (CKD) often presents with elevated serum phosphorus levels and end-stage renal failure because renal insufficiency can reduce urinary phosphate excretion and lead to hyperphosphataemia [3,4]. Clinical observations indicate that hyperphosphataemia is closely associated with various clinical relevant pathologies, such as kidney function deterioration, secondary hyperparathyroidism, renal osteodystrophy, and metastatic calcification [5ā8]. Controlling phosphate imbalance in CKD patients is considered a crucial factor in improving the prognosis of patients receiving haemodialysis [9].
Trace elements, toxic metals, and metalloids in kidney disease
2021, Nutritional Management of Renal Disease, Fourth EditionĪ±Klotho and Chronic Kidney Disease
2016, Vitamins and Hormones
Supported in part by US Public Health Service NIDDK Grants No. DK 09976, DK 07126, and RR-00036.
Copyright Ā© 1992 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.